International Therapeutics Licenses RNAi Quantification Product to Rosetta

Sep 28, 2004

NEW YORK, Sept. 28 (GenomeWeb News) - International Therapeutics has granted to Rosetta Inpharmatics a worldwide nonexclusive license to its ProxiQuant technology for research and development applications, IT said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Re-Think on Science Standards

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Graves Wins Top Australian Science Prize

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

Faster Efforts

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

This Week in Cell

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.

Main menu